Product category:
Antibodies
News Release from: Oxford BioMedica
Edited by the Laboratorytalk Editorial
Team on 31 July 2006
Oxford Biomedica - Innurex programme
Oxford BioMedica is announcing that its Innurex programme for nerve regeneration in spinal cord injury has been awarded $150,000 from the Christopher Reeve Paralysis Foundation
At the time of the Annual General Meeting on the 20th April 2004 Oxford BioMedica released an update statement which said that "the company is announcing that its Innurex programme for nerve regeneration in spinal cord injury has been awarded $150,000 from the Christopher Reeve Paralysis Foundation" The company wishes to make it clear that the Christopher Reeve Paralysis Foundation has awarded the grant to Kings College London to explore the use of Innurex in spinal cord injury
This study, at King's College, is being conducted in collaboration with Oxford BioMedica and the company retains all commercial rights.
• Oxford BioMedica: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
